Arria and colleagues found that college students who used prescription stimulants nonmedically did not show GPA increases or detectable academic advantages over peers
Recognizing these exclusive benefits can guide individuals and medical practitioners toward selecting a suitable peptide that targets particular therapeutic goals or health-related circumstances
Pharmacol Rep 66:169173 Dungan KM, Povedano ST, Forst T, Gonzlez JGG, Atisso C, Sealls W, Fahrbach JL (2014) Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Intriguingly, the association of these pharmacological classes may represent a promising therapeutic strategy, and some clinical studies have already shown adjunctive benefits of the combination therapy